GU Cancers 2018 | MRI-based prostate cancer diagnosis: economic and logistical considerations

Mark Emberton

The take-home message from the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, on MRI for prostate cancer diagnosis was positive. However, this leaves us with a variety of questions. In this interview, filmed at the meeting, Mark Emberton, MD, FRCS, of University College London, London, UK, gives us a concise and comprehensive summary of the economic and logistical issues with the use of MRI for prostate cancer diagnosis, including accessibility and changes to the previously straightforward diagnostic pathway.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter